Otolaryngologic clinics of North AmericaHumansNeoplasm RecurrenceLocalSquamous Cell Carcinoma of Head and NeckHead and Neck Neoplasms
Novel Treatment Approaches in Recurrent/Metastatic Squamous Head and Neck Cancer.
Sandra Llop, Pablo Jiménez-Labaig, Ilaria Micheletto, Nabil F Saba, Ben O'Leary
Published: 202610.1016/j.otc.2025.08.009
Abstract
The prognosis of recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) remains poor, with most patients presenting with primary or acquired resistance to immune checkpoint inhibitors (ICIs). Upon progression on ICIs, the only standard of…
Preview only. Read the full abstract at the source